SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-18-009751
Filing Date
2018-04-30
Accepted
2018-04-30 13:12:24
Documents
2
Effectiveness Date
2018-04-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A nvus-defa14a_20180621.htm DEFA14A 30141
2 GRAPHIC g2018042704030718723541.jpg GRAPHIC 84275
  Complete submission text file 0001564590-18-009751.txt   147475
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36620 | Film No.: 18788222
SIC: 2834 Pharmaceutical Preparations